Half-dose r-SAK before heart stent procedure for heart attack
Part of Heart & circulation clinical trials.
This trial tests whether a half-dose medicine called r-SAK given before a primary PCI heart stent procedure improves outcomes and safety in people with a specific type of heart attack. It may help the heart recover better, but it also checks the risk of side effects like bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old and weigh at least 45 kg
- Your chest pain lasted 30 minutes or more and your ECG shows specific ST-segment changes of a heart attack
- Your persistent chest pain started within the last 12 hours before you’re randomized
- You are scheduled for a primary PCI (emergency stent procedure) between 30 and 120 minutes from now
- You do not have serious bleeding risk or active bleeding, and you are not on blood thinners (anticoagulants)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a specific stent (with no polymer coating) plus a single blood thinner plan with aspirin and another P2Y12 medicine is as safe and effective as the standard two-medicine plan after a STEMI heart attack. It may help people avoid longer exposure to stronger blood-thinning if the new approach works as well.
This trial tests whether a blood thinner called rivaroxaban helps improve slow blood flow in heart arteries after a stent placement for a heart attack. It may help reduce complications by keeping the arteries open better.
This trial looks at whether using heart imaging (OCT or angiogram) to guide how long you take two blood thinners after a heart attack (STEMI) can be safe and effective. If you qualify, your doctor may be able to reduce your blood thinner use sooner, which could lower bleeding risk while still protecting your heart.
This trial tests different blood thinner medicines after a heart stent is placed. It aims to find the best way to prevent blood clots while reducing bleeding risk.
This trial compares two ways to treat a major heart attack: using a drug-coated balloon or a drug-eluting stent. If you are having a heart attack and need emergency angioplasty, you may qualify if your artery blockages meet specific size limits and you have no bleeding risks or allergies to the medicines used.
This trial tests whether adding a low dose of a clot-busting medicine to the standard emergency procedure to open blocked heart arteries can improve outcomes for people having a heart attack. It aims to see if the combination is safe and more effective than the standard procedure alone.
Hear when a new ST Elevation Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.